Brazil Says It’s Ready and Willing to Break AIDS Drugs Patents

    According to Pedro Chequer, the coordinator of Brazil’s Sexually Transmitted Disease/Aids program, the country may break patents with pharmaceutical companies and manufacture generic versions of up to a total of five brand name retroviral drugs.

    “There is a concrete possibility that we will break patents under existing international agreements. And we now have the technical capacity to begin manufacturing next year. We will be able to deal with the manufacturing process all the way from the molecular level to the finished product,” he said.


    However, Chequer refused to specifiy which AIDS drugs, out of the eight Brazil presently has to import, could have their patents broken.


    He also did not disclose the amount of money Brazil was spending on research, but he did say that the Brazilian Development Bank (BNDES), along with laboratories in both the public and private sectors, were running studies on the country’s capabilities with the objective of eventually creating a new reality with new perspectives in the pharmaceutical area.


    “What this means is that besides the seven AIDS drugs we already make generic versions of, we will expand our production capacity significantly with another three to five generic versions of other brand name drugs,” said Chequer.


    The justification for breaking patents, explained Chequer, is that Brazil is forced to spend too much on imported AIDS drugs which could be made domestically in public or private labs.


    He points out that around 80% of his budget (some US$ 165 million or R$ 450 million) goes to paying for the importation of only seven drugs that are used in treating AIDS.


    Brazil’s Sexually Transmitted Disease/AIDS program, as part of the Brazilian public health network (SUS), supplies approximately 150,000 HIV-positive patients with 15 drugs free of charge to treat the disease and keep it under control.


    Out of those 15 drugs, seven are now produced in Brazil in generic versions and the remaining eight are imported. Among the eight imported drugs is the newest in the so-called AIDS cocktail, Aazanavir, which is made in the United States by Bristol-Myers Squibb.


    Agência Brasil
    Translator: Allen Bennett

    Tags:

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    A Lot to Share

    It was from Kerala that the Portuguese collected pepper and introduced it in Brazil. ...

    Ford Ecosport designed and made in Brazil

    Ford to Launch EcoSport, Designed in Brazil, to Be Sold All Over the World

    Ford’s CEO and president Alan Mulally announced to Brazil’s president, Luiz Inácio Lula da ...

    Japan’s Minister Visits Brazilian Ethanol Plant

    Brazilian Minister of Agriculture, Roberto Rodrigues, was in the city of Pradópolis, in the ...

    Brazil’s Minister Goes on National TV to Announce Withdrawal from IMF

    Brazil’s Minister of Finance, Antonio Palocci, announced on national television and radio network, this ...

    Tales of the Trembling Earth

    A roar made the house shake. A blood cascade gushed over the man! The ...

    Brazilian chicken

    China Gives Green Light to Brazilian Chicken

    Once again Brazil will be able to export chicken meat to China, which is ...

    Brazil and Arabs Break New Trading Records

    Trade between Brazil and the Arab countries broke new records in July. Bilateral trade, ...

    Wind energy

    Brazil Gathers 50 Countries to Discuss Sustainable Energy

    Held in Brazil the Global Renewable Energy Forum after four days of debate on ...

    Asylum to Ecuador’s Leader Is Not Political Act, Says Brazil

    Brazil’s ambassador in Ecuador, Sérgio Florêncio, said Monday, April 25, that the concession of ...

    Brazil Tumbles While Waiting Interest Rate News

    Latin American markets turned decidedly lower today, after a positive session yesterday. Negative regional ...